Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
VHX-896 by Vanda Pharmaceuticals for Bipolar I Disorder: Likelihood of Approval
VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Bipolar I Disorder. According to GlobalData,...
Data Insights
VHX-896 by Vanda Pharmaceuticals for Schizophrenia: Likelihood of Approval
VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III...